Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Mateus de Oliveira Taveira et al.|Nature Cancer|2020Cited by 271
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancerChristina Hartl, Michael S. Goldberg|Journal for ImmunoTherapy of Cancer|2019Cited by 36
860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancerAnita K. Mehta, Jennifer L. Guerriero, Emily Cheney et al.|Unknown|2020Cited by 25
Abstract P5-04-01: PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing the anti-tumor potential of TAMsJennifer L. Guerriero, Elizabeth A. Mittendorf, Anita K. Mehta et al.|Cancer Research|2020Cited by 0